Clinical Trial Update: Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2a study evaluating MVA-BN-RSV vaccination with RSV challenge in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• MVA-BN-RSV

Snippet

Sponsor: Bavarian Nordic | Conditions: RSV Infection | Phase 2 | Status: COMPLETED